Every single Mesoblast blinded controlled clinical trial has FAILED to achieve the primary end point. Every single one. The only trial that Mesoblast claims to have been successful was a small single arm open label trial with "theoretical controls" and a belated effort to provide group matched controls instead of individual matched controls. With no validated potency assay the FDA rightly said it was inadequate evidence of efficacy.
Infact the trial more closely resembled the previous phase 2 trial for the same treatment when it was called prochymal. Again an open label trial on 30 patients with aGVHD and a "promising" response rate.
https://ashpublications.org/blood/a...Phase-II-Trial-of-ProchymalT-Ex-Vivo-Cultured
But when it came to trying to replicate the results with a larger, blinded controlled phase 3 cinical trial it failed to produce the goods, not once but TWICE.
Novartis likely had a good look at the trial data for the Covid-ARDS trial that was stopped for futility and SI claimed was "successful. Then they walked away. Doesn't that tell you anything?
It's a crock.
- Forums
- ASX - By Stock
- Back pain trial
Every single Mesoblast blinded controlled clinical trial has...
Featured News
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
TG1
TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
Add MSB (ASX) to my watchlist
|
|||||
Last
99.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.136B |
Open | High | Low | Value | Volume |
97.0¢ | $1.01 | 96.5¢ | $2.783M | 2.823M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
20 | 84682 | 99.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.5¢ | 12683 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 74793 | 0.990 |
17 | 130214 | 0.985 |
16 | 203120 | 0.980 |
9 | 245215 | 0.975 |
12 | 581089 | 0.970 |
Price($) | Vol. | No. |
---|---|---|
0.995 | 31944 | 14 |
1.000 | 136021 | 15 |
1.005 | 294961 | 14 |
1.010 | 224427 | 9 |
1.015 | 81843 | 5 |
Last trade - 12.00pm 02/08/2024 (20 minute delay) ? |
Featured News
MTL
Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
MSB (ASX) Chart |